Evaluation the use of ramipril and candesartan for COVID-19 inpatiens with hypertension comorbid at RSUD dr. moewardi
Jurnal Kefarmasian Indonesia
; 13(1):75-82, 2023.
Article
in Indonesian
| GIM | ID: covidwho-2312768
ABSTRACT
Hypertension is the most common comorbid in patients infected by COVID-19. Drugs often given for the treatment of hypertension, namely ramipril, and candesartan, are thought to increase the development of COVID-19 because the angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARBs) increase the expression of ACE-2, which is the binding site of SARS-CoV-2. This study aims to analyze the effect of using ramipril and candesartan on healing in hospitalized patients with COVID-19 with hypertension at RSUD dr. Moewardi in 2020. This study was conducted retrospectively. The results were presented descriptively and used medical record data of hospitalized patients with COVID-19 with comorbid hypertension at RSUD dr. Moewardi in 2020. Using ramipril and candesartan affects patient recovery in terms of length of stay (LOS), symptom relief, and RT-PCR test results. Analysis of the research data using SPSS with Spearman correlation test. The Spearman correlation test showed that there was a fairly strong relationship between the use of ramipril and candesartan in patients with COVID-19 with comorbid hypertension on LOS, symptom relief, and RT-PCR test results. The study results show that using ramipril and candesartan can improve the recovery of patients with COVID-19 with comorbid hypertension. ACEI and ARB drugs have not been proven to worsen the patient's condition so their use can be continued.
human diseases; hypertension; coronavirus disease 2019; patients; viral diseases; drug therapy; blood pressure; comorbidity; angiotensin-converting enzyme 2; binding sites; retrospective studies; symptoms; Severe acute respiratory syndrome coronavirus 2; man; Indonesia; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; APEC countries; ASEAN Countries; high Human Development Index countries; lower-middle income countries; South East Asia; Asia; ramipril; candesartan; SARS-CoV-2; high blood pressure; viral infections; chemotherapy; binding site
Full text:
Available
Collection:
Databases of international organizations
Database:
GIM
Type of study:
Experimental Studies
Language:
Indonesian
Journal:
Jurnal Kefarmasian Indonesia
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS